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AIM To describe existing evidence on non-pharmacological interventions to manage sleep
disturbance in children with neurodisabilities.
METHOD We systematically reviewed non-pharmacological interventions aimed at improving
non-respiratory sleep disturbance in children with neurodisability. Sixteen databases, grey
literature, and reference lists of included papers were searched up to February 2017. Two
researchers (B.B., C.M., G.S., A.S., A.P.) undertook screening, data extraction, and quality
appraisal.
RESULTS Twenty-five studies were included: 11 randomized controlled trials and 14 before-
and-after studies. All studies were at high or unclear risk of bias. Parent-directed
interventions were categorized as comprehensive tailored interventions (n=9), comprehensive
non-tailored interventions (n=8), and non-comprehensive interventions (n=2). Six ‘other’ non-
pharmacological interventions were included. Seventy-one child and parent sleep-related
outcomes were measured across the included studies. We report the two most commonly
measured outcomes: the Child Sleep Habits Questionnaire and sleep onset latency. Five
studies reported significant improvements on at least one of these outcomes.
INTERPRETATION Various types of non-pharmacological intervention for managing sleep
disturbance have been evaluated. Clinical heterogeneity and poor study quality meant we
could not draw definitive conclusions on the effectiveness of these interventions. Current
clinical guidance recommends parent-directed interventions as the first approach to
managing sleep disturbance; prioritizing research in this area is recommended.
Non-respiratory sleep disturbances are more prevalent in
children with neurodisabilities than in typically developing
children.1,2 Sleep problems can affect quality of life, school
performance, and daytime behaviour.3,4 Child sleep prob-
lems are also associated with poor outcomes for parents
and other members of the household.5
Current guidance on management of sleep disturbance
in children proposes that once clinical or respiratory rea-
sons for sleep disturbance are excluded, interventions that
aim to change parents’ management of their child’s sleep
should be the ‘first port of call’.6 This guidance is
regarded as applicable to children with neurodisability.
Pharmacological interventions (such as melatonin) are rec-
ommended where such interventions prove ineffective or
alongside parent-directed approaches.7,8 Other non-phar-
macological approaches include chronotherapy, photother-
apy, dietary interventions, sensory interventions (e.g.
weighted blankets), cranial osteopathy, and environmental
changes.
Previous systematic reviews in the field of managing
sleep disturbance in children with neurodisabilities have
mainly focused on individual diagnoses9–14 and/or a
specific intervention or pharmacological intervention
only.10,13–15 A systematic review was therefore commis-
sioned by the UK National Institute for Health Research
(NIHR), Health Technology Assessment (HTA) Pro-
gramme to collate the existing evidence across multiple
interventions and neurodisabilities.
We aimed to assess the effectiveness of non-pharmacolo-
gical interventions for non-respiratory sleep disturbance in
children with neurodisabilities and to identify priorities for
future primary research. The review reported here is part
of a broader review, which also included pharmacological
interventions and will be available as an NIHR HTA
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journal report (https://www.journalslibrary.nihr.ac.uk/pro
grammes/hta/1421202/#/).
METHOD
The review was conducted in accordance with the Centre for
Reviews and Dissemination’s guidance for undertaking
reviews in health care16 and reported according to the
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines.17 The review was prospec-
tively registered with PROSPERO (registration number
CRD42016034067).18 As this paper represents a systematic
review of published work, ethical approval was not required.
Eligibility criteria
Studies were assessed against the eligibility criteria
described in the following sections.
Population
Children and young people (0–18y) with neurodisability and
experiencing non-respiratory sleep disturbance were included.
Neurodisability was defined in accordance with the consensus
definition of Morris et al.19 Non-respiratory sleep distur-
bances of any duration relating to initiation, maintenance, or
scheduling of sleep, diagnosed by a health care professional
on the basis of parental/carer or child report or sleep observa-
tion, were included. Central disorders of hypersomnolence
and sleep-related movement disorders were excluded.
Intervention
Non-pharmacological interventions aimed at improving
sleep initiation, maintenance, scheduling, or quality in any
setting, which are relevant to the care provided by statutory
health care services across the UK, were included. Interven-
tions had to meet current practice standards20 on the basis of
guidance from clinical members of the team (e.g. interven-
tions that involved punishment were not eligible).
Comparator(s)
Studies using no comparator, wait list control, placebo, or
other active intervention were eligible.
Outcomes
The primary outcomes of interest were child- and parent-
related sleep. These included actigraphy-based and parent/
carer- or child-reported measures (e.g. sleep diaries, or
standardized scales relating to initiation, maintenance,
scheduling, or quality of sleep).
Secondary outcomes included child-related quality of
life; daytime behaviour and cognition; parent/carer quality
of life and well-being including global quality of life, phys-
ical well-being, mental well-being, mental health (e.g.
stress) and family functioning; and adverse events.
Study design
Randomized controlled trials (RCTs), non-randomized
controlled studies, and before-and-after studies were eligi-
ble. Case studies were excluded.
Search strategy
An information specialist searched the following electronic
databases in February and March 2016 and updated the
search in February 2017: Applied Social Sciences Index of
Abstracts (ASSIA); The Cochrane Central Register of Con-
trolled Trials (CENTRAL); Cochrane Database of System-
atic Reviews; Conference Proceedings Citation Index;
Cumulative Index of Nursing and Allied Health Literature
(CINAHL); Database of Abstracts of Reviews of Effects;
Embase; Health Management Information Consortium;
MEDLINE; MEDLINE In-Process; PsycINFO; Science
Citation Index; Social Care Online; and Social Policy &
Practice. ClinicalTrials.gov; World Health Organization
International Clinical Trials Registry Platform; and the UK
Clinical Trials Gateway were also searched for ongoing and
completed trials. An example search strategy (for ASSIA) is
provided in Appendix S1 (online supporting information).
There were no restrictions on date, language, or study
design.
Study selection and data extraction
The search results were downloaded into Endnote biblio-
graphic software (Clarivate Analytics, Philadelphia, PA,
USA) and deduplicated. The first 10% of titles were screened
independently by two researchers (B.B., C.M., G.S., A.S.,
A.P.). Once agreement had been reached, a single researcher
(A.S., A.P.) screened the remainder. Two researchers (B.B.,
C.M., G.S., A.S., A.P.) independently screened the abstracts
of the records identified as potentially relevant on the basis
of their title. Full papers were independently screened by
two researchers (B.B., C.M., G.S., A.S., A.P.). Discrepancies
were resolved through discussion and consensus with a third
researcher (C.M.) if necessary. Data extraction forms were
developed and piloted in Microsoft Word 2010 and Excel
2010. Data extracted included details of study design,
descriptions of the intervention and comparator, outcome
measures, and methods of assessment. Outcome data were
extracted to allow calculation of the mean difference and
95% confidence interval (CI) between groups to assist com-
parison between studies. Data extraction was undertaken by
one researcher and checked by a second (A.S., A.P.).
Quality assessment
Risk of bias was assessed using the Cochrane Risk Of Bias
Tool for RCTs,21 A Cochrane Risk Of Bias Assessment
Tool for Non-Randomized Studies of Interventions for
other studies with a control group,22,23 or an adapted
What this paper adds
• Existing evidence on non-pharmacological interventions to manage sleep
disturbance in children with neurodisabilities is predominately of poor
quality.
• Most included studies evaluated parent-directed interventions of varying
content and intensity.
• There was very little consistency between studies in the outcome measures
used.
• There is some evidence that parent-directed interventions may improve child
outcomes.
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checklist for before-and-after studies.24 For crossover trials,
we also assessed whether an appropriate analysis using
paired data was conducted and whether there was a treat-
ment-by-period interaction.25 Assessment of risk of bias was
undertaken independently by two researchers (B.B., C.M.,
G.S., A.S., A.P.), with discrepancies resolved through con-
sensus, or discussion with a third researcher (C.M.).
Strategy for data synthesis
The substantial heterogeneity of interventions, study
design, and outcome measures across studies meant
meta-analysis was not appropriate. Therefore, narrative
summaries are used to describe the available evidence.
Interventions were assigned to the following categories:
parent-directed and ‘other’ non-pharmacological interven-
tions (Appendix S2, online supporting information).
Parent-directed interventions were defined as psycho-
educational interventions aiming to teach parents knowl-
edge and skills to manage their child’s sleep disturbance
and possibly to provide support to parents as they imple-
ment new knowledge and skills. Modes of delivering such
interventions include one-to-one sessions, group work,
one-off workshops, and provision of written material.
Given the variety within this category of intervention,
these were classified in terms of their content (comprehen-
sive vs non-comprehensive) and the degree to which they
were personalized to the individual child (tailored vs non-
tailored). The following intervention typology was created:
(1) Comprehensive tailored: a detailed assessment guides
the decision-making regarding the management of a
specific child’s sleep disturbance. A sleep management
plan specific to the child/family is developed, and
training in implementing that plan is delivered. There
is ongoing support and advice as parents implement
changes to sleep management strategies and practices
(‘implementation support’). A comprehensive approach
is used involving training across sleep and sleep pro-
cesses, sleep hygiene, and the management of specific
problem behaviours (e.g. night wakings).
(2) Comprehensive non-tailored: a standard ‘training cur-
riculum’ is used which is comprehensive in content and
may include opportunities for a parent to be supported
to operationalize the material learnt to their child’s sleep
disturbance. Implementation support may also be
included.
(3) Non-comprehensive: intervention focuses on a single
topic area related to managing sleep disturbance (e.g.
sleep hygiene, behavioural strategies); these may be
tailored or non-tailored.
Other types of non-pharmacological intervention
included interventions such as complementary therapies
and weighted blankets.
Studies were grouped by intervention type, study objec-
tive (evaluations of intervention effectiveness, evaluations
of different modes of delivering an intervention or inten-
sity of support), and then by study design (RCT and non-
randomized study designs) for the synthesis.
RESULTS
Overview of the evidence
After deduplication, 15 745 titles were screened and 25
studies investigating non-pharmacological interventions
were included (Fig. 1). A list of excluded studies is avail-
able from the authors.
Table I summarizes key study characteristics, grouped
by the type of intervention evaluated. Eleven RCTs, one
controlled before-and-after study, and 14 uncontrolled
before-and-after studies were included. Studies were con-
ducted in the UK (n=9), USA (n=7), Australia (n=5), and
one each in Canada, Hong Kong, Israel, and China. Sam-
ple sizes ranged from 5 to 244 participants.
The mean age of children ranged from 2 years 8 months
to 12 years 1 month. Thirteen studies included children
with two or more neurodisabilities. In nine studies, partici-
pants were described as having a single neurodisability diag-
nosis: autism spectrum disorder (n=6) or attention-deficit–
hyperactivity disorder (ADHD) (n=3). The remaining three
studies offered no detail on the types of neurodisability rep-
resented; generic terms such as ‘mental retardation’ were
used. Most studies included children with a mix of sleep dis-
turbances, with the most commonly reported being sleep
initiation and maintenance (n=14 studies). The first time-
point at which outcomes were measured once the interven-
tion was completed ranged from immediately after interven-
tion to 2 months after intervention. Five trials collected
outcome data at additional follow-up time points; however,
to minimize heterogeneity in results we only report out-
comes measured closest to the end of the intervention.
Risk of bias
Poor reporting of study methods and results was found
across all study designs. All RCTs were assessed as having
high risk of bias for most items on the Cochrane Risk of
Bias tool because of issues with randomization and incom-
plete outcome data. We were unable to find a registered
protocol for 10 RCTs,5,26–34 and in all RCTs blinded out-
come assessment was either not undertaken or it was
unclear whether blinding had occurred.5,26–32,34–36 How-
ever, we do note that the type of interventions and out-
comes under investigation make robust, blinded outcome
assessment challenging. Although the use of actigraphy
data may be considered more objective than parent-
reported data in terms of the measurement of some sleep
outcomes, we did not consider these to be true objective
outcomes with non-blinding likely to introduce bias.
Non-randomized studies were at high (n=12) or unclear
(n=2) risk of bias. This was mainly because of how studies
selected participants (e.g. not reporting eligibility crite-
ria)37–50 and likely or unclear bias in measurement of inter-
vention outcomes.39,40,43–46,51
Outcomes
Seventy-one sleep-related outcomes were reported across
the included studies. Given the number of outcomes
Review 3
assessed, in this paper we only report the two most com-
monly measured outcomes: Child Sleep Habits Question-
naire (CSHQ),52 and sleep onset latency (SOL). The
CSHQ is a parent-report questionnaire which is widely
used to measure sleep disturbance. The questionnaire has
33 items, rated on a 3-point Likert scale. Items are
grouped into the following subscales: bedtime resistance,
sleep onset delay, sleep duration, sleep anxiety, night wak-
ings, parasomnias, sleep disordered breathing, and daytime
sleepiness. A total score offers an overall measure of sleep
disturbance, with higher scores indicating a greater severity
of sleep disturbance, owing to either the frequency (i.e.
regularity) or number of different behaviours presenting.
However, caution is needed when using the scale as the
sole method of assessing a child’s sleep problems as a num-
ber of subscales showed low construct validity and diagnos-
tic validity.53 No clinically important difference has been
established for either the CSHQ or SOL. At least one of
these outcomes was reported by most included studies. Six
studies did not report either of these out-
comes.26,34,36,37,43,46 Full data on all outcomes are provided
in the HTA report (https://www.journalslibrary.nihr.ac.uk/
programmes/hta/1421202/#/).
Results from studies
Parent-directed: comprehensive tailored interventions
Five RCTs5,27–29,35 and four before-and-after stud-
ies5,43,50,51 evaluated comprehensive tailored interventions,
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Figure 1: Flow chart of the study selection process. [Colour figure can be viewed at wileyonlinelibrary.com].
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delivered face-to-face (at home and/or in clinic) (Table II).
The duration of the intervention, the number of sessions
delivered, and the extent of implementation support varied
across studies.
Of the five RCTs, three used a no-intervention compara-
tor,27,28,35 and two evaluated alternative ways of delivering
an intervention: one compared the mode of implementation
support (home visit vs telephone call);5 and the other com-
pared the intensity of practitioner involvement when deliver-
ing the intervention (brief vs extended).29
CSHQ. Four RCTs (n=310)5,28,29,35 and two before-and-
after studies (n=20)5,50 reported the CSHQ total score, a
validated parent-reported global assessment of child sleep
(Table III). One RCT, which was classified as having low
risk of bias on all domains except for performance bias
(n=244), reported a statistically significant reduction (i.e.
improvement) in total CSHQ score after intervention for
the ADHD-specific intervention compared with usual care
(adjusted mean difference 6.6, 95% CI: 8.5 to 4.6).35
Another smaller RCT (n=26) reported a similar magnitude
of effect but was not statistically significant (mean differ-
ence 4.62, 95% CI: 10.83 to 1.59).28 In one before-
and-after study there was an improvement in total CSHQ
score after intervention compared with preintervention
(mean difference 7.9, 95% CI: 14.4 to 1.3).50
For the two trials investigating alternative approaches to
delivering the intervention, no statistically significant dif-
ference in CSHQ score was observed.5,29
SOL. One RCT (n=40)27 and two before-and-after stud-
ies (n=21)50,51 measured SOL, the time from bedtime to
sleep onset. There was no statistically significant difference
in actigraphy-measured SOL (verified using sleep diaries)
Table II: Details of comprehensive tailored interventions (active arms only)
Study
Total duration of
intervention
(including
implementation
support)
Mode of delivery of
assessment and parent
training (excluding imple-
mentation support)
Mode of delivering imple-
mentation support, and
intensity, once regular
sessions with practitioner
completed
Intervention
developed
for specific
neurodisability? Manual?
Length of
follow-up
Number of sessions (loca-
tion)
Randomized controlled trials
Beresford
et al.5
10wks Face-to-face.
One (home)
Home visit: approximately
weekly for 6–8wks.
Versus telephone call:
approximately weekly for
6–8wks
No No 10wks,
22wks
Hiscock
et al.35
4wks Face-to-face.
One (home or clinic)
Face-to-face (n=1), later
followed by telephone
call (n=1)
Yes, attention-
deficit–
hyperactivity
disorder
No 3mo, 6mo
Johnson
et al.27
Not reported Face-to-face.
Five (home and clinic)
Face-to-face (n=1) Yes, autism
spectrum
disorder
Yes 1mo, 2mo
Moss et al.28 15wks Teaching workshops and
face-to-face.
Two workshops and one
face-to-face (home)
Home visit (n=1), followed
by telephone calls, ‘on a
needs basis for
approximately 2mo’
No Yes 15wks,
23wks
Sciberras
et al.29
One session
vs 4wks
Face-to-face.
One (clinic) vs two (clinic)
None
Versus telephone call
(n=1) followed by face-to-
face session (clinic) if
needed
Yes, attention-
deficit–hyperactivity
disorder
No 2mo
Before-and-after studies
Austin
et al.50
15wks Teaching workshops and
face-to-face.
Two workshops and one
home visit and one
workshop
Approximately weekly
telephone call for 6wk
period
No Yes 19wks
Beresford
et al.5
12–16wks Face-to-face.
Two (clinic, home)
Fortnightly sessions at
clinic
No No 12wks,
24wks
Quine
and Wade43
6–28wks Face-to-face.
Two (home)
Described as ‘weekly’
home visits, although
study authors also report
frequency decided
between practitioner and
parent and diminishing
in intensity
No Yes 3mo
Weiskop
et al.51
Minimum
7wks
Face-to-face.
Four (mix of home and
clinic), plus at least
weekly telephone contact
between sessions
‘Review session’ 5wks
after session 4; telephone
calls ‘gradually reduced’
after session 5
No Yes 3mo,
12mo
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in the RCT of a comprehensive tailored intervention com-
pared with an attention placebo control (non-sleep-related
parent education) (mean difference 4min, 95% CI: 15.0
to 23.0).27 One before and after the study also reported no
statistically significant difference before and after the inter-
vention in sleep-diary-measured SOL (mean difference
43min, 95% CI: 30 to 116);50 the second presented the
results as graphs with no numerical data available.51
Parent-directed: comprehensive non-tailored interventions
Three RCTs and five before-and-after studies evaluated
comprehensive non-tailored interventions.26,30,31,38,44,48,54
Various modes of delivery were used across the studies
(Table IV). They also varied in the extent to which they
accommodated the specific information and training needs
parents might have had for their child’s condition and/or
sleep problem. Some included telephone implementation
support, whereas others did not.
One RCT compared a sleep training curriculum deliv-
ered by a booklet with no intervention;30 one compared
two modes of delivering the same curriculum group versus
individual face-to-face sessions supplemented by weekly
telephone calls;31 and one compared group with individual
delivery of a training curriculum.26 The before-and-after
studies evaluated a group-delivered intervention;38,42,48 a
single session workshop;41 and an individually delivered
intervention.44
CSHQ. One RCT (n=80)31 and four before-and-after
studies (n=126)38,41,42,48 reported CSHQ total score. The
RCT reported no statistically significant difference for this
outcome between delivery of the training curriculum via a
group or a single face-to-face session (not possible to cal-
culate effect estimate and 95% CI).31 Two before-and-after
studies, one evaluating a three-session group-delivered
intervention48 and the other a four-session group-delivered
intervention plus implementation support,38 reported sta-
tistically significant improvements (i.e. a decrease) in
CSHQ total score after intervention compared with prein-
tervention (mean difference 6.9, 95% CI: 2.6 to
11.248 and mean difference 3.3, 95% CI: 1.4 to
5.338 respectively). For the two other before-and-after
studies, the mean difference in total CSHQ score could
not be calculated before and after the intervention as the
samples were not matched. However, the studies reported
small or very small effect sizes of 0.20 and 0.02.41
SOL. Two RCTs (n=116)30,31 and two before-and-after
studies (n=40)44,48 reported SOL. No statistically significant
difference in SOL was observed in the RCT comparing a
non-tailored intervention with no intervention (mean differ-
ence 11.8, 95% CI: 37.3 to 13.7),30 the RCT comparing
individual versus group delivery of the same training curricu-
lum (mean difference 0.2, 95% CI: 9.9 to 9.5),31 or in the
before-and-after study of a group-delivered intervention (data
not presented, narrative report provided only).48 The second
before-and-after study reported a statistically significant
reduction in SOL after receipt of a non-tailored comprehen-
sive intervention delivered by a single face-to-face session
(mean difference42.8, 95% CI: 6.01 to24.6).44
Parent-directed: non-comprehensive interventions
One RCT and one before-and-after study34,47 evaluated
non-comprehensive interventions (Table V).
The RCT (n=30) evaluated an intervention that focused
specifically on behavioural principles of managing problem
sleep.34 The comparator was an attention control. Neither
CSHQ nor SOL were reported in this study. The before-
and-after study (n=23) evaluated an intervention47 that
trained parents of children with ADHD on the principles
of sleep hygiene only. This study reported a statistically
significant improvement in CSHQ total score at 6 weeks
after intervention (mean difference 6.4, 95% CI: 4.3–8.5).
Other non-pharmacological interventions
Two RCTs and four before-and-after studies evaluated
other types of non-pharmacological intervention (Tables I
and VI).32,36,37,39,40,46
CSHQ. One study reported the CSHQ; there was a sta-
tistically significant reduction in total CSHQ score in the
before-and-after study after acupuncture and ear point tap-
ing (mean difference 11.5, 95% CI: 13.3 to 9.7).39
Table III: Outcome results for Child Sleep Habits Questionnaire for comprehensive tailored interventions
Study Baseline, mean (SD) Follow-up, mean (SD) Mean differencea (95% CI)
Randomized controlled trials
Beresford et al.5 I: 59.50 (11.82)
C: 53.33 (4.27)
I: 52.17 (11.44)
C: 53.33 (8.76)
1.16 (14.27 to 1.95)a
Hiscock et al.35 I: 57.8 (8.8)
C: 59.0 (7.8)
I: 50.1 (8.3)
C: 55.1 (8.6)
Adjusted: 6.6 (8.5 to 4.6)b
5.0 (7.6 to 2.4)a
Moss et al.28 I: 56.20 (9.38)
C: 51.38 (7.54)
I: 46.50 (7.29)
C: 51.12 (6.51)
4.62 (10.83 to 1.59)a
Sciberras et al.29 NR I: (change score) 5.09 (5.12)
C: (change score) 6.82 (8.02)
1.73 (7.11 to 3.65)c
Before-and-after studies
Austin et al.50 55.43 (7.68) 47.57 (9.14) 7.86 (14.39 to 1.33)a
Beresford et al.5 59.55 (7.59) 56.57 (10.77) Cannot be estimated.d Effect size given as 0.42.
aUnadjusted mean difference unless otherwise stated. bReported in paper. cDifference in change scores from baseline to 2mo between
intervention and control groups. dAs not a matched sample (n=11 preintervention and n=7 postintervention). I, intervention; C, comparator;
NR, Not reported
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SOL. One RCT (n=73)32 and one before-and-after study
(n=8)40 measured SOL. There was no statistically signifi-
cant difference for this outcome in the RCT comparing
weighted blankets with placebo blankets32 (actigraphy-mea-
sured SOL: mean difference 2.1, 95% CI: 5.5 to 9.7; par-
ent reported: mean difference 1.6, 95% CI: 6.7 to 3.5).
There was also no statistically significant difference in par-
ent-reported SOL in a before-and-after study evaluating an
aquatic exercise intervention (mean difference 19.11, 95%
CI: 40.95 to 6.57).40
DISCUSSION
Principal findings
This systematic review has identified a lack of high-quality
evidence assessing the effectiveness of non-pharmacological
interventions to manage sleep disturbance in children with
neurodisabilities.
Three-quarters of the studies evaluated parent-directed
interventions. We found no replication of studies or more
than one study evaluating the same intervention. This lack
of evidence is noteworthy given that parent-directed inter-
ventions are recommended as the ‘first port of call’ for
clinicians seeking to manage sleep disturbance in children
with neurodisabilities. Less than half the evidence came
from RCTs, and all of these had substantial or unclear risk
of bias; therefore their findings need to be treated with
some caution.
Several of the parent-directed interventions showed evi-
dence of benefit. One before-and-after study reported a
significant reduction in SOL after a comprehensive non-
tailored intervention delivered by a single face-to-face ses-
sion.44 In relation to total CSHQ score, one RCT of a
comprehensive tailored intervention developed specifically
for children with ADHD, and rated as being at low risk of
bias for all domains except blinding,35 reported a statisti-
cally significant improvement on this outcome measure.
Additionally, two before-and-after studies evaluating com-
prehensive non-tailored interventions delivered via
groups,38,48 and one before-and-after study of a non-com-
prehensive intervention (ADHD-specific) also showed sta-
tistically significant improvements in total CSHQ score.47
As far as we are aware, a minimum clinically important dif-
ference for the CSHQ has not yet been established; there-
fore the clinical significance of these findings is unclear.
We would note that where RCTs did not show evidence
of statistically significant benefit for outcomes, this too
needs to be interpreted cautiously as ‘no evidence of effect’
does not mean there is ‘evidence of no effect’.54
For the RCTs that were comparing parent-directed inter-
ventions in terms of mode of delivery or intensity of support,
the evaluation question is different and is concerned with
comparing the effectiveness of alternative (in the case of this
review, more and less resource intensive) ways of providing
an intervention.5,27,29,31 In three of these trials,5,29,31 no sig-
nificant differences in outcomes, as assessed by CHSQ
scores and/or SOL, were reported. The remaining trial27
did not use these outcome measures. Again, we reiterate theTa
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caution with which these findings should be treated given
the reported issues with study quality, the lack of any repli-
cation, and the absence of a rubric by which the clinical sig-
nificance of observed effects can be judged.
Comparison with other research
Our results support the findings of Brown et al.,55 who, in
2013, reviewed evidence on non-pharmacological interven-
tions to manage sleep disturbance in children with
neurodevelopmental disorders, or cognitive and/or visual
impairment. Their preliminary scoping searches suggested
that most studies, particularly those with a more robust
design, had not yet reported and so it was considered too
early to attempt a systematic review of RCTs. Instead, the
authors conducted a critical review and concluded that
there is little conclusive evidence on non-pharmacological
interventions in this population. In contrast, a recent sys-
tematic review of parent-directed sleep management inter-
ventions for non-disabled children aged 5 years and under
concluded that there was ‘moderate support’ for these
interventions. The authors recommended parent-directed
interventions to be implemented without hesitation for
typically developing young children.56
Existing evidence on non-pharmacological interventions
for sleep disturbance in children with neurodisabilities pro-
vides little clarity as to the effectiveness of these interven-
tions. Given the poor quality and inconclusive nature of
available evidence, there is a need for high-quality RCTs
assessing their effectiveness and cost-effectiveness. This
needs to include trials evaluating the relative effectiveness of
alternative ways of delivering interventions. In addition,
given the nature of parent-directed interventions, trials
should be designed so that the impact of relevant parent,
child, and impairment characteristics on effectiveness can be
tested. In 2017, Sciberras et al.57 published a protocol for a
large RCT (n=320) that assessed the effectiveness and cost-
effectiveness of a comprehensive tailored intervention in
improving sleep in children with ADHD. Described as a
translational study, it evaluated one of the interventions
included in this review34 in terms of effectiveness (and cost-
effectiveness) when delivered in clinical settings by paediatri-
cians or psychologists. Recruitment to this trial was com-
pleted in October 2016; however, findings have not yet been
published. This RCT will make an important contribution
to the evidence base when the results are reported. However,
given the diversity of the patient group and the number of
non-pharmacological interventions available, additional
RCTs and replication studies – conducted in settings where
the intervention can be delivered as routine practice and
across all (relevant) neurodisabilities – are required. Finally,
going forward, we would note the importance of detailed
reporting of the interventions using a standardized checklist
for describing complex interventions.58
Strengths and weaknesses of the research
This review provides a comprehensive overview of the evi-
dence available on non-pharmacological interventions to
manage sleep disturbance for children with neurodisabili-
ties. We present only the most commonly reported child
sleep outcomes in this paper owing to the vast number of
unique outcome measures reported. The full results will be
available in an NIHR HTA report (https://www.journal
slibrary.nihr.ac.uk/programmes/hta/1421202/#/), which
reaches the same conclusions as drawn in this paper. We
undertook systematic searches of 16 databases for pub-
lished, unpublished, and ongoing studies. There were no
language restrictions and we included one study published
in Chinese. As with all systematic reviews, there was a pas-
sage of time between the last date of the literature searches
(February 2017) and publication. As a result, there may be
one or more studies that have subsequently been published
which meet our review’s inclusion criteria that are not
included here. Our searches of trial registries identified five
trials that will be completing over the next couple of years,
so an update to this review may then be warranted. Stan-
dard methods to reduce error and bias at key stages of the
review were used. For example, screening and quality
assessment were undertaken independently by two
researchers (B.B., C.M., G.S., A.S., A.P.). We developed a
typology of parent-directed interventions in the way we
believe was most meaningful after discussion among mem-
bers of the team. We hope this makes a useful conceptual
contribution to understanding and specifying such interven-
tions. Although others may have found an alternative way to
group these interventions, we do not believe it would
change the conclusions of this review. We strictly followed
the guidance for completing the Cochrane Risk of Bias tool,
meaning that studies were downgraded for lack of blinding,
which is difficult to achieve with these types of intervention.
This affected one study, which had a low risk of bias on all
other criteria.35 Had we applied the Cochrane criteria ‘less
strictly’, this study would have been rated as having low risk
of bias. (It is this intervention that is, as noted earlier, cur-
rently subject to a translational trial).57 This raises an
important issue for studies in this area, as classifying studies
as having a high risk of bias will mean that non-pharmaco-
logical evidence will always seem weaker than studies of
pharmacological evidence. At the same time, in the absence
of an established method of blinded outcome assessment,
there is a risk of overestimating the effectiveness of an inter-
vention where allocation is unblinded and parent-reported
outcomes have an element of subjectivity.
Unanswered questions and further research
The substantial health, social, and economic effects of
sleep deprivation mean this lack of robust evidence needs
to be addressed. A recent UK national research prioritiza-
tion exercise for children with neurodisability ranked the
management of sleep disturbance in the top 10 research
priorities.59 We therefore argue for strategic investment on
this topic and our proposed research recommendations are
set out below.
However, we note that, on the basis of this review’s
findings, it is difficult to closely specify where such
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research should be focused. We suggest that attention is
paid to interventions that are feasible to deliver in routine
practice. Furthermore, acknowledging the resource con-
straints of public services and, as was done by some studies
reviewed and where appropriate, evaluations should com-
pare lower and higher intensity modes of delivery (e.g.
direct vs remote contact between parent and professional;
qualifications of staff delivering the intervention; text-based
information/advice vs face-to-face session). Finally, we
would argue there is no strong case for developing new
interventions. Going forward, the focus should be on fur-
ther evaluation of existing interventions that appear, on the
basis of this review, to have some degree of promise, have
(if relevant) been manualized, and are relevant to the ways
in which health care is delivered.
First, high-quality RCTs assessing non-pharmacological
interventions for sleep disturbance in children with neurodis-
ability are needed. These RCTs should assess the key ques-
tions of what works, for whom, and in what circumstances.
Intervention development would benefit from being informed
by mixed methods research into the mechanisms by which
non-pharmacological interventions may affect a child’s sleep.
A theory-driven approach to intervention development and
evaluation is essential if we are to gain understanding of an
intervention’s active ingredients and the factors that may
moderate or mediate their therapeutic action.60–62
Second, non-pharmacological interventions for managing
sleep disturbance in children with neurodisability are ‘com-
plex interventions’, made up of several interacting ele-
ments. Future research may benefit from adopting the UK
Medical Research Council’s framework on developing and
evaluating complex interventions.63 This would enable
robust approaches to the development and evaluation of
complex interventions to be adopted that are grounded in
theory.60 Future research publications should ensure that
interventions are described in sufficient detail for replica-
tion, for example through use of the Template for Inter-
vention Description and Replication (TIDieR) checklist.58
Third, none of the included studies were presented as
preventive interventions. The brief, less intense, parent-
directed interventions reviewed may align with a preventive
or early intervention approach. Evaluating the impact of
these interventions on preventing the development of sleep
disturbance, or preventing a newly emerging sleep distur-
bance increasing in severity, would be beneficial.
Fourth, future evaluations should include an economic
evaluation, including consideration of costs to families as
well as to service providers.
Finally, future research to establish a method of blinded
outcome assessment in this area would be beneficial. Addi-
tionally, methodologists may wish to consider how to
grade lack of blinding in studies where blinding is not pos-
sible and outcomes are subjective.
CONCLUSIONS
A wide range of non-pharmacological interventions have
been evaluated for managing sleep disturbance in children
with neurodisabilities. Although there is some evidence
that parent-directed interventions may improve outcomes
for children, it was not possible to draw definitive conclu-
sions owing to the lack of robust evidence and substantial
heterogeneity across studies. Current clinical guidance rec-
ommends parent-directed interventions should be the first
approach to managing sleep disturbance; prioritizing
research in this area is therefore recommended.
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